Document is current
Any future updates will be listed below
-
Authors
Radicati, Fabiana Giada
Vacca, Laura
Casali, Miriam
Tremigliozzi, Ilaria
Alborghetti, Marika
Lombardi, Martina
Rossini, Paolo Maria
Stocchi, Fabrizio https://orcid.org/0000-0002-5763-0033
-
Funding
Funding for this research was provided by:
Ministero della Salute (Ministero della Salute)
- License Information
-
More Information
Article History
Received: 4 April 2025
Accepted: 17 September 2025
First Online: 12 November 2025
Declarations
:
: This study was a randomized, cross-over, double blind trial (clinicaltrial.gov: NCT02734485). The study was designed and carried out according to the Declaration of Helsinki and approved by the IRCCS San Raffaele Pisana Ethics Committee. All participants signed an informed consent prior to the start of any study procedures.
: NA.
: Fabrizio Stocchi reports honoraria and consulting fees from Britannia Pharmaceuticals, Contera, Lundbeck, Novartis, Teva, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Roche, Biogen, ACimmune and Zambon. Marika Alborghetti has been sponsored by Lundbeck Italia and NextStepPharma for educational activity, received travel grants from Zambon and Lundbeck Italia, and research grants from Sapienza University of Rome, outside of the present work. All the other authors declare that there are no additional disclosures to report.
